Ignite Creation Date:
2024-05-06 @ 7:11 PM
Last Modification Date:
2024-10-26 @ 3:02 PM
Study NCT ID:
NCT05925530
Status:
RECRUITING
Last Update Posted:
2024-03-05
First Post:
2023-06-22
Brief Title:
Study to Assess Neoadjuvant Durvalumab D and Platinum-Based Chemotherapy CT Followed by Either Surgery and Adjuvant D or CRT and Consolidation D in Resectable or Borderline Resectable Stage IIB-IIIB NSCLC MDT-BRIDGE
Sponsor:
AstraZeneca
Organization:
AstraZeneca